SCIENTIFIC EVIDENCE

ANKRD29, as a new prognostic and immunological biomarker of non-small cell lung cancer, inhibits cell growth and migration by regulating MAPK signaling pathway

Biology direct

Zhao H, Wang Y, He Y, Zhang P, Zeng C, Du T, Shen Q, Zhao S.

Publication Overview

Key findings, Countstar context, and access to the original paper.

2023

Cancer Research

Immunology

Key Finding

This study examines ANKRD29 in lung cancer.

Countstar Connection

The researchers counted cells with the Countstar IC1000.

Stay Connected to

Get new publications, application notes, cell analysis insights, and Countstar updates delivered to your inbox.

Meet us online